(Q40056945)
Statements
Germline mutations of MEK in cardio-facio-cutaneous syndrome are sensitive to MEK and RAF inhibition: implications for therapeutic options (English)
Thanaset Senawong
Janyaporn Phuchareon
Frank McCormick
Katherine A Rauen
2 November 2007